Marocaine Ste de Therapeutique SA (SOT)

Casablanca

Currency in MAD

SOT Pro Research

365.00

+1.00(+0.27%)

Closed·07/08

Fair Value

Unlock Value

Day's Range

360.00

375.00

52 wk Range

304.00

395.00

SOT Income Statement

Assess the Marocaine Ste de Therapeutique income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the SOT net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

2,055.88

2,301.83

2,486

2,815.9

3,225.67

Total Revenues Growth

aa.aa

+14.35%

+11.96%

+8%

+13.27%

+14.55%

Cost Of Revenues

aa.aa

1,035.3

1,203.12

1,335.04

1,488.12

1,676.42

Gross Profit

aa.aa

1,020.58

1,098.71

1,150.96

1,327.78

1,549.25

Gross Profit Growth

aa.aa

+15.48%

+7.66%

+4.76%

+15.36%

+16.68%

Gross Profit Margin %

aa.aa

49.64%

47.73%

46.3%

47.15%

48.03%

Other Operating Expenses, Total

aa.aa

561.16

616.05

756

767.12

821.89

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+14.91%	+9.78%	+22.72%	+1.47%	+7.14%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	542.4	604.7	683.37	730.61	791.49
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-35.86	-45.83	17.99	-31.45	-35.84

Operating Income

aa.aa

459.41

482.66

394.96

560.67

727.36

Operating Income Growth

aa.aa

+16.17%

+5.06%

-18.17%

+41.95%

+29.73%

EBIT Margin %

aa.aa

22.35%

20.97%

15.89%

19.91%

22.55%

Net Interest Expenses

aa.aa

-8.73

-9.57

-19.9

-30.57

-22.98

Net Interest Expenses Growth

aa.aa

+10.74%

-9.62%

-107.92%

-53.66%

+24.84%

Interest Expense, Total

aa.aa

-9.11

-10.03

-20.36

-31.21

-23.46

Interest And Investment Income

aa.aa

0.38

0.46

0.47

0.64

0.48

Other Non Operating Expenses, Total

aa.aa

2.67

6.44

18.95

6.77

18.03

EBT, Excl. Unusual Items

aa.aa

453.35

479.54

394.01

536.86

722.42

Gain (Loss) On Sale Of Assets

aa.aa

0.03

73.34

-0.07

0.01

Other Unusual Items, Total

aa.aa

-45.96

-56.08

-79.76

-57.26

-98.6

EBT, Incl. Unusual Items

aa.aa

407.42

416.92

387.6

492.71

623.99

EBT, Incl. Unusual Items Growth

aa.aa

+18.88%

+2.33%

-7.03%

+27.12%

+26.64%

EBT, Incl. Unusual Items Margin

aa.aa

19.82%

18.11%

15.59%

17.5%

19.34%

Income Tax Expense

aa.aa

132.48

149.79

123.85

175.48

235.76

Net Income to Company

aa.aa

274.95

267.13

263.75

317.22

388.23

Minority Interest

aa.aa

3.9

-0.52

-0.99

-1.94

-2.7

Net Income

aa.aa

278.85

266.62

262.76

315.29

385.53

Net Income Growth

aa.aa

+21.13%

-4.39%

-1.45%

+19.99%

+22.28%

Net Income Margin %

aa.aa

13.56%

11.58%

10.57%

11.2%

11.95%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

278.85

266.62

262.76

315.29

385.53

Basic EPS - Continuing Operations

aa.aa

7.75

7.41

7.3

8.76

10.14

Basic EPS - Continuing Operations Growth

aa.aa

+21.13%

-4.39%

-1.45%

+19.99%

+15.74%

Diluted EPS - Continuing Operations

aa.aa

7.74

7.4

7.3

8.76

10.14

Diluted EPS - Continuing Operations Growth

aa.aa

+21.04%

-4.39%

-1.37%

+19.99%

+15.74%

Basic Weighted Average Shares Outstanding

aa.aa

38.03

Diluted Weighted Average Shares Outstanding

aa.aa

38.03

Dividend Per Share

aa.aa

3.4

5.6

6.6

Dividend Per Share Growth

aa.aa

+376.19%

-32%

+64.71%

+17.86%

EBITDA

aa.aa

514.04

539.84

449.6

628.62

767.76

EBITDA Growth

aa.aa

+16.81%

+5.02%

-16.72%

+39.82%

+22.13%

EBITDA Margin %

aa.aa

25%

23.45%

18.09%

22.32%

23.8%

EBIT

aa.aa

459.41

482.66

394.96

560.67

727.36

* In Millions of MAD (except for per share items)

FAQ

What was Marocaine Ste de Therapeutique’s revenue at year end?

At the end of the last reported fiscal year, Marocaine Ste de Therapeutique (SOT) recorded total revenue of 3,225.67 million MAD.

How much revenue did Marocaine Ste de Therapeutique report in the most recent quarter?

In its most recent quarterly earnings report, Marocaine Ste de Therapeutique posted revenue of 1,676.41 million MAD.

What was Marocaine Ste de Therapeutique’s net income for the year?

For the full year, Marocaine Ste de Therapeutique reported net income of 385.53 million MAD.

How much net income did Marocaine Ste de Therapeutique post in the last quarter?

In the most recent quarter, Marocaine Ste de Therapeutique (SOT) posted net income of 191.82 million MAD.

What was Marocaine Ste de Therapeutique’s gross profit for the year?

Gross profit for the year was reported at 1,549.25 million MAD.

How much gross profit did Marocaine Ste de Therapeutique generate last quarter?

Marocaine Ste de Therapeutique recorded gross profit of 826.80 million MAD in its latest quarterly report.

What was Marocaine Ste de Therapeutique’s annual operating income?

For the full year, Marocaine Ste de Therapeutique (SOT) reported operating income of 727.36 million MAD.

What was Marocaine Ste de Therapeutique’s operating income last quarter?

Quarterly operating income was 376.63 million MAD.

What was Marocaine Ste de Therapeutique’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 382.48 million MAD.

What was the quarter-over-quarter change in EBITDA for Marocaine Ste de Therapeutique?

EBITDA changed by -0.73% million MAD compared to the last quarter.

How did Marocaine Ste de Therapeutique’s revenue change compared to the previous quarter?

Revenue changed by 8.21% million MAD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Marocaine Ste de Therapeutique?

In the latest quarter, gross profit changed by 14.44% million MAD from the previous quarter.

S&P/TSX

36,381.23

+244.92

+0.68%

S&P/TSX 60

2,139.10

+7.23

+0.34%

US 30

54,015.90

+130.7

+0.24%

US 500

7,753.40

+43.4

+0.56%

S&P 500 VIX

14.90

-0.25

-1.65%

DAX

26,319.45

+179.32

+0.69%

Dollar Index

99.48

-0.330

-0.33%

Market Movers

Name	Last	Chg. %	Vol.
Enbridge	71.55	-1.17%	13.15M
RBC	294.59	-0.66%	2.65M
Bank of Montreal	253.24	-0.09%	2.59M
Shopify Inc	211.37	+2.40%	3.06M
Toronto Dominion Bank	169.30	-0.39%	3.79M
Suncor Energy	83.83	-2.57%	7.05M
Barrick Mining	60.96	+4.96%	8.30M

Name	Last	Chg. %	Vol.
1933 Industries	0.01	+200.00%	692.50K
FuelPositive	0.070	+133.33%	2.26M
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
James Bay Resources Ltd	0.020	+100.00%	1.47K
Digicann Ventures	0.010	+100.00%	2.00K
ePlay Digital	0.010	+100.00%	7.00K
1933 Industries	0.0100	+100.00%	692.50K

Name	Last	Chg. %	Vol.
Beckett’s	0.01	-100.00%	10.15K
Big Bear Gold	0.07	-78.33%	15.00K
Lanebury Growth Capital	0.05	-68.75%	18.17K
Albert Labs International	0.005	-50.00%	1.00K
Champion Electric	0.005	-50.00%	39.00K
International Iconic Gold Exploration	0.0050	-50.00%	276.00K
Red Lake Gold	0.0050	-50.00%	51.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Celestica Inc.	443.51	+0.19%	541.78K
TELUS	13.53	-1.60%	8.51M
Bank of Montreal	253.24	-0.09%	2.59M
Equinox Gold	16.16	+7.16%	7.24M
Alamos Gold	46.26	+6.00%	1.28M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaa Aaaa	2.860	+58.57%	4.535
Aaaaaaa	34.74	+56.97%	54.53
A Aaaaaaaaaaaaaa	104.38	+51.98%	158.64
A Aaaaaaa	8.70	+48.61%	12.93
Aaaaa Aaaaa	5.31	+47.28%	7.82
Aaaaaaaaaaaa	142.78	+46.84%	209.66
Aaaaa Aa	0.47	+45.43%	0.68

Name	Last	Upside	Fair Value
Aaa Aaaa	2.860	+58.57%	4.535
Aaaaaaa	34.74	+56.97%	54.53
A Aaaaaaaaaaaaaa	104.38	+51.98%	158.64
A Aaaaaaa	8.70	+48.61%	12.93
Aaaaa Aaaaa	5.31	+47.28%	7.82
Aaaaaaaaaaaa	142.78	+46.84%	209.66
Aaaaa Aa	0.47	+45.43%	0.68

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Marocaine Ste de Therapeutique SA (SOT)

SOT Income Statement

FAQ

What was Marocaine Ste de Therapeutique’s revenue at year end?

How much revenue did Marocaine Ste de Therapeutique report in the most recent quarter?

What was Marocaine Ste de Therapeutique’s net income for the year?

How much net income did Marocaine Ste de Therapeutique post in the last quarter?

What was Marocaine Ste de Therapeutique’s gross profit for the year?

How much gross profit did Marocaine Ste de Therapeutique generate last quarter?

What was Marocaine Ste de Therapeutique’s annual operating income?

What was Marocaine Ste de Therapeutique’s operating income last quarter?

What was Marocaine Ste de Therapeutique’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Marocaine Ste de Therapeutique?

How did Marocaine Ste de Therapeutique’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Marocaine Ste de Therapeutique?

Trending Stocks